Up Front
Noted
In Depth
In Focus
Events
DEALS ANALYSIS
APAC deals surge as North America struggles for growth
China saw a 32% growth in deals activity in Q3 2020, pushing well ahead of the USA which saw only 8% growth over the same timeframe.
JOBS ANALYSIS
Is Eli Lilly going all-in on artifical intelligence?
Eli Lilly opened more new roles in August than any other company in the pharma sector. 30% of these roles were in the artifical Intelligence sector. Is this a sign that they are going all in on AI?